Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The goal of this study was to determine the role of nitric oxide in disruption of the blood-brain barrier during acute hypertension. We examined the microcirculation of the cerebrum in vivo. Permeability of the blood-brain barrier was quantitated by the formation of venular leaky sites and clearance of fluorescent-labeled albumin (FITC-albumin) before and during phenylephrine-induced acute hypertension. We compared disruption of the blood-brain barrier during acute hypertension in untreated rats and in rats treated for 1 h with topical application ofNG-monomethyl-l-arginine (l-NMMA; 100 μM) orNG-nitro-l-arginine methyl ester (l-NAME; 100 μM). Under control conditions, no venular leaky sites were visible and clearance of FITC-albumin was minimal in untreated rats and in rats treated with topical application of nitric oxide synthase inhibitors. Phenylephrine (20 μg/kg/min for 5 min) infusion increased systemic arterial pressure by a similar magnitude in all groups of rats and produced disruption of the blood-brain barrier in venules. However, the magnitude of disruption of the blood-brain barrier during acute hypertension was significantly less in rats treated withl-NMMA (52% reduction in the clearance of FITC-albumin) andl-NAME (47% reduction in clearance of FITC-albumin). The findings of the present study suggest that synthesis/release of nitric oxide contributes to disruption of the blood-brain barrier during acute hypertension.

Original languageEnglish (US)
Pages (from-to)99-103
Number of pages5
JournalBrain Research
Volume686
Issue number1
DOIs
StatePublished - Jul 17 1995

Fingerprint

Blood-Brain Barrier
Nitric Oxide
Hypertension
Phenylephrine
Venules
Cerebrum
Microcirculation
Nitric Oxide Synthase
Arginine
Albumins
Permeability
Arterial Pressure
FITC-albumin

Keywords

  • Fluorescein isothiocyanate albumin
  • Microcirculation
  • Pial venule
  • Rat
  • l-NAME
  • l-NMMA

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension. / Mayhan, William G.

In: Brain Research, Vol. 686, No. 1, 17.07.1995, p. 99-103.

Research output: Contribution to journalArticle

@article{246ffe88aa554f90ac6f34a628339d37,
title = "Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension",
abstract = "The goal of this study was to determine the role of nitric oxide in disruption of the blood-brain barrier during acute hypertension. We examined the microcirculation of the cerebrum in vivo. Permeability of the blood-brain barrier was quantitated by the formation of venular leaky sites and clearance of fluorescent-labeled albumin (FITC-albumin) before and during phenylephrine-induced acute hypertension. We compared disruption of the blood-brain barrier during acute hypertension in untreated rats and in rats treated for 1 h with topical application ofNG-monomethyl-l-arginine (l-NMMA; 100 μM) orNG-nitro-l-arginine methyl ester (l-NAME; 100 μM). Under control conditions, no venular leaky sites were visible and clearance of FITC-albumin was minimal in untreated rats and in rats treated with topical application of nitric oxide synthase inhibitors. Phenylephrine (20 μg/kg/min for 5 min) infusion increased systemic arterial pressure by a similar magnitude in all groups of rats and produced disruption of the blood-brain barrier in venules. However, the magnitude of disruption of the blood-brain barrier during acute hypertension was significantly less in rats treated withl-NMMA (52{\%} reduction in the clearance of FITC-albumin) andl-NAME (47{\%} reduction in clearance of FITC-albumin). The findings of the present study suggest that synthesis/release of nitric oxide contributes to disruption of the blood-brain barrier during acute hypertension.",
keywords = "Fluorescein isothiocyanate albumin, Microcirculation, Pial venule, Rat, l-NAME, l-NMMA",
author = "Mayhan, {William G.}",
year = "1995",
month = "7",
day = "17",
doi = "10.1016/0006-8993(95)00460-8",
language = "English (US)",
volume = "686",
pages = "99--103",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension

AU - Mayhan, William G.

PY - 1995/7/17

Y1 - 1995/7/17

N2 - The goal of this study was to determine the role of nitric oxide in disruption of the blood-brain barrier during acute hypertension. We examined the microcirculation of the cerebrum in vivo. Permeability of the blood-brain barrier was quantitated by the formation of venular leaky sites and clearance of fluorescent-labeled albumin (FITC-albumin) before and during phenylephrine-induced acute hypertension. We compared disruption of the blood-brain barrier during acute hypertension in untreated rats and in rats treated for 1 h with topical application ofNG-monomethyl-l-arginine (l-NMMA; 100 μM) orNG-nitro-l-arginine methyl ester (l-NAME; 100 μM). Under control conditions, no venular leaky sites were visible and clearance of FITC-albumin was minimal in untreated rats and in rats treated with topical application of nitric oxide synthase inhibitors. Phenylephrine (20 μg/kg/min for 5 min) infusion increased systemic arterial pressure by a similar magnitude in all groups of rats and produced disruption of the blood-brain barrier in venules. However, the magnitude of disruption of the blood-brain barrier during acute hypertension was significantly less in rats treated withl-NMMA (52% reduction in the clearance of FITC-albumin) andl-NAME (47% reduction in clearance of FITC-albumin). The findings of the present study suggest that synthesis/release of nitric oxide contributes to disruption of the blood-brain barrier during acute hypertension.

AB - The goal of this study was to determine the role of nitric oxide in disruption of the blood-brain barrier during acute hypertension. We examined the microcirculation of the cerebrum in vivo. Permeability of the blood-brain barrier was quantitated by the formation of venular leaky sites and clearance of fluorescent-labeled albumin (FITC-albumin) before and during phenylephrine-induced acute hypertension. We compared disruption of the blood-brain barrier during acute hypertension in untreated rats and in rats treated for 1 h with topical application ofNG-monomethyl-l-arginine (l-NMMA; 100 μM) orNG-nitro-l-arginine methyl ester (l-NAME; 100 μM). Under control conditions, no venular leaky sites were visible and clearance of FITC-albumin was minimal in untreated rats and in rats treated with topical application of nitric oxide synthase inhibitors. Phenylephrine (20 μg/kg/min for 5 min) infusion increased systemic arterial pressure by a similar magnitude in all groups of rats and produced disruption of the blood-brain barrier in venules. However, the magnitude of disruption of the blood-brain barrier during acute hypertension was significantly less in rats treated withl-NMMA (52% reduction in the clearance of FITC-albumin) andl-NAME (47% reduction in clearance of FITC-albumin). The findings of the present study suggest that synthesis/release of nitric oxide contributes to disruption of the blood-brain barrier during acute hypertension.

KW - Fluorescein isothiocyanate albumin

KW - Microcirculation

KW - Pial venule

KW - Rat

KW - l-NAME

KW - l-NMMA

UR - http://www.scopus.com/inward/record.url?scp=0029078001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029078001&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(95)00460-8

DO - 10.1016/0006-8993(95)00460-8

M3 - Article

C2 - 7583277

AN - SCOPUS:0029078001

VL - 686

SP - 99

EP - 103

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -